AEMD - Aethlon Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.79M
Enterprise Value 3
3.45M
Trailing P/E
N/A
Forward P/E 1
-0.89
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
34.46
Price/Book (mrq)
23.48
Enterprise Value/Revenue 3
31.39
Enterprise Value/EBITDA 6
-0.55

Trading Information

Stock Price History

Beta (3Y Monthly) 0.42
52-Week Change 3-84.85%
S&P500 52-Week Change 318.19%
52 Week High 325.6500
52 Week Low 32.0500
50-Day Moving Average 33.3676
200-Day Moving Average 34.2877

Share Statistics

Avg Vol (3 month) 328.3k
Avg Vol (10 day) 340.3k
Shares Outstanding 51.44M
Float 1.36M
% Held by Insiders 16.64%
% Held by Institutions 114.95%
Shares Short (Nov 15, 2019) 48.52k
Short Ratio (Nov 15, 2019) 40.21
Short % of Float (Nov 15, 2019) 40.67%
Short % of Shares Outstanding (Nov 15, 2019) 40.59%
Shares Short (prior month Oct 15, 2019) 414.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3Oct 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,773.22%

Management Effectiveness

Return on Assets (ttm)-121.12%
Return on Equity (ttm)-368.97%

Income Statement

Revenue (ttm)110k
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)229.62k
EBITDA -6.33M
Net Income Avi to Common (ttm)-7.43M
Diluted EPS (ttm)-5.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)785.66k
Total Cash Per Share (mrq)0.55
Total Debt (mrq)187.49k
Total Debt/Equity (mrq)906.95
Current Ratio (mrq)0.77
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-4.8M
Levered Free Cash Flow (ttm)-2.02M